UK3CR is the UK Collaborative for Cancer Clinical Research. We enable the UK’s leading clinical cancer researchers to co-ordinate best practice, initiate collaborations and connect with strategic partners.
Our members are multi-disciplinary groups of clinical experts in all cancer types, based throughout the four nations of the UK. Their voices inform the development of new clinical trials and research initiatives across the cancer research landscape, both nationally and internationally.
Hosted by the Association of Medical Research Charities and funded by the UK Government’s Office for Life Sciences via the UKRI Medical Research Council, we connect our members with research funders from the charitable and commercial sectors. This means investment in cancer research can be targeted at areas of the highest clinical priority, maximising opportunities for the UK to lead in cancer clinical research and unlocking the country’s vast potential to support medical innovation and growth.
The UK Collaborative for Cancer Clinical Research (UK3CR) has been set up by the UK Government’s Office for Life Sciences, as part of the Cancer Healthcare Goals Programme.
The Association of Medical Research Charities is host to the UK3CR. Two-thirds of cancer research investment in the UK is funded by charities, with nearly half of our 150+ strong membership funding research into cancer of some form.
UK3CR was created on World Cancer Day 2025, to provide central co-ordination for Cancer Research Groups originally created by the National Cancer Research Institute (NCRI).
Providing a hub for central co-ordination enables these groups to continue to collaborate – with many now supported administratively by AMRC member charities after the NCRI’s closure.
We also work to facilitate connections between our member groups and the devolved UK governments, industry partners, Clinical Trials Units and other stakeholders to promote investment and growth in UK clinical cancer research.
Clinical Lead
Pippa Corrie qualified in medicine at Oxford University, having previously undertaken a PhD in anticancer drug development. She has been a Consultant Medical Oncologist at Addenbrooke’s Hospital, Cambridge, since 1997 and is an Affiliated Assistant Professor in the University of Cambridge. She has over 30 years of experience in clinical and translational research, leading academic and commercial sponsored trials, as well as holding national roles in both the former National Cancer Research Institute (chairing the skin cancer group and subsequently the pancreatic cancer group) and NIHR Clinical Research Network, overseeing clinical research development and delivery. During her time from 2017 until 2024 as NIHR Cancer National Specialty Lead, Pippa had international responsibilities supporting the EORTC Trials Liaison Office and the International Rare Cancers Initiative and she played a major role setting up the Cancer Vaccines Innovation Pathway. She continues to provide cancer specialty leadership for the NIHR Eastern Regional Research Delivery Network.
Pippa is recognised nationally and internationally as a leading specialist in melanoma and pancreatic cancer management and research. She has been and is currently Chief Investigator of several NIHR portfolio academic multi-centre studies, (including AVAST-M, INTERIM, SIEGE, MITRE, PREMIUM and PemOla. Most of these trials have included industry partnerships. She is a co-founder of the national Melanoma Focus charity, which supports both patients and professionals. As a strong advocate for early career researchers, she contributed to the national roll-out of the NIHR Associate PI scheme. She has published over 160 peer reviewed papers.
In her spare time, she enjoys walking, running and improving on her Park Run 5K time! She loves to cook and spend time with family.
“I am delighted to take on the role as Clinical Lead for the newly created UK Collaborative for Cancer Clinical Research (UK3CR). This is such a great opportunity to help facilitate relationships and cohesion between all stakeholders involved in cancer clinical research with a shared aim of improving outcomes for our patients”
Programme Manager
[email protected]
Glen has a background working in research funding for AMRC member charity Bowel Research UK, as well as roles in Parliament and local politics.
He is in charge of operations for UK3CR and works closely with the wider AMRC team and UK3CR Clinical Lead.